These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25122664)

  • 21. Population-Based Study on Patterns of Cardiac Stress Testing After Percutaneous Coronary Intervention.
    Bagai A; Eberg M; Koh M; Cheema AN; Yan AT; Dhoot A; Bhavnani SP; Wijeysundera HC; Bhatia RS; Kaul P; Goodman SG; Ko DT
    Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 29017997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
    Nakao K; Yasuda S; Nishimura K; Noguchi T; Nakai M; Miyamoto Y; Sumita Y; Shishido T; Anzai T; Ito H; Tsutsui H; Saito Y; Komuro I; Ogawa H
    J Am Heart Assoc; 2019 Apr; 8(7):e009692. PubMed ID: 30909774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
    Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
    Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex Differences in Cardiac Medication Use Post-Catheterization in Patients Undergoing Coronary Angiography for Stable Angina with Nonobstructive Coronary Artery Disease.
    Galway S; Adatia F; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Sep; 26(9):976-983. PubMed ID: 28384013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal Medical Therapy for Known Coronary Artery Disease: A Review.
    Gibbons RJ; Miller TD
    JAMA Cardiol; 2017 Sep; 2(9):1030-1035. PubMed ID: 28700788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Optimal Medical Therapy in Patients With Cardiovascular Disease Undergoing Cardiac Rehabilitation.
    Jafri SH; Hushcha P; Dorbala P; Bousquet G; Lutfy C; Mellett L; Sonis L; Blankstein R; Cannon C; Plutzky J; Polk D; Skali H
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt A):102058. PubMed ID: 37640175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
    Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
    Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Depression and Adherence to Guideline-Directed Medical Therapies Following Percutaneous Coronary Intervention.
    Lapa ME; Swabe GM; Rollman BL; Muldoon MF; Thurston RC; Magnani JW
    JAMA Netw Open; 2022 Dec; 5(12):e2246317. PubMed ID: 36508214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of medical management in coronary artery disease.
    Al Shammeri O; Stafford RS; Alzenaidi A; Al-Hutaly B; Abdulmonem A
    Ann Saudi Med; 2014; 34(6):488-93. PubMed ID: 25971821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The State of Percutaneous Intervention in Stable Coronary Artery Disease.
    Drescher C; Rao SV
    Curr Atheroscler Rep; 2020 Jul; 22(8):42. PubMed ID: 32671483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Trends in Adherence to Secondary Prevention Guidelines for Patients Undergoing Coronary Revascularization in Washington State: An Analysis of the Clinical Outcomes Assessment Program (COAP) Registry.
    Riley RF; Don CW; Aldea GS; Mokadam NA; Probstfield J; Maynard C; Goss JR
    J Am Heart Assoc; 2012 Aug; 1(5):e002733. PubMed ID: 26600570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal medical therapy and percutaneous coronary intervention for stable angina: why patients should 'be taking' and 'keep taking' the tablets.
    Mohee K; Wheatcroft SB
    J Clin Pharm Ther; 2014 Aug; 39(4):331-3. PubMed ID: 24754310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal medical therapy in patients with stable coronary artery disease in Poland: the ISCHEMIA trial experience.
    Pracoń R; Demkow M; Anthopolos R; Mazurek T; Drożdż J; Witkowski A; Gajos G; Pruszczyk P; Roik M; Łoboz-Grudzień K; Lesiak M; Reczuch K; Kalarus Z; Kryczka K; Henzel J; Kaczmarska-Dyrda E; Maksym J; Jonik S; Krekora J; Celińska-Spodar M; Jaroch J; Łanocha M; Szulik M; Szwed H; Rużyłło W
    Pol Arch Intern Med; 2021 Nov; 131(11):. PubMed ID: 34585554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-Based Optimal Medical Therapy and Mortality in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention.
    Lee K; Han S; Lee M; Kim DW; Kwon J; Park GM; Park MW
    J Am Heart Assoc; 2023 May; 12(10):e024370. PubMed ID: 37158100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.